GET THE APP

Predefined Diets in Inflammatory Bowel Disease Patients: A S | 94509

プライマリヘルスケア: オープンアクセス

ISSN - 2167-1079

概要

Predefined Diets in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis

Emily Ashford

IBD is a chronic disease mediated by the immune system that is distinguished by the importance of diet in pathological development. The purpose of this study is to learn how the use of predefined diets affects the adult population with IBD. A systematic review and meta-analysis were carried out. We discovered 4195 records using various databases (MEDLINE, Scopus, Cochrane, LILACS, CINAHL, and WOS). Following a review process, only 31 research studies were chosen for qualitative synthesis and 10 for meta-analysis. The variables used were: Crohn's Disease Activity Index (CDAI) for Crohn's Disease (CD) patients and faecal calprotectin (FC), C-Reactive Protein (CRP), and Albumin (ALB) for IBD patients. Prescribed diets are partially effective in the treatment of IBD and are compatible with other medical treatments. CDAI improved, but with reservations due to the high heterogeneity of the data, whereas ALB, FC, and CRP showed no differences. Because diets and the tools used to measure their effects vary so greatly, more studies evaluating the impact of predefined diets on IBD patients are required.

免責事項: この要約は人工知能ツールを使用して翻訳されたものであり、まだレビューまたは検証されていません。